zymenex
Chiesi snaps up Zymenex
August 29, 2013Sales and Marketing Chiesi, lamazym, rare diseases, zymenex
Chiesi Group is to acquire biopharma company Zymenex Holdings, allowing the Italian firm to enter the rare disease arena for …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
